SAW
ZOM

Signal Advisors Wealth’s Zomedica Corp. ZOM Stock Holding History

Signal Advisors Wealth’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25,100
Closed -$1.46K – 551
2025
Q1 		$1.46K Hold
25,100
– – ﹤0.01% 430
2024
Q4 		$3.01K Hold
25,100
– – ﹤0.01% 424
2024
Q3 		$3.44K Buy
25,100
+100
+0.4% +$14 ﹤0.01% 416
2024
Q2 		$3.65K Buy
25,000
+9,900
+66% +$1.48K 0.01% 75
2024
Q1 		$2.2K Buy
+15,100
New +$2.11K ﹤0.01% 292

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return
RF
Rossby Financial Melbourne, Florida $547M AUM 30.65% 1-Year Est. Return

Signal Advisors Wealth's ZOM Position: Q2 2025 in Review

Signal Advisors Wealth sold out of Zomedica Corp. (ZOM) in Q2 2025, closing a stake of 25,100 shares — an estimated $1.46K sold.

Signal Advisors Wealth first reported a position in ZOM in Q1 2024 and held it in 5 quarters. The position peaked at $3.65K in Q2 2024. 10 funds tracked by Wall St. Rank hold ZOM as of Q2 2025.

  • Signal Advisors Wealth reported no remaining Zomedica Corp. position as of Q2 2025 after selling out during the quarter.
  • Signal Advisors Wealth sold 25,100 Zomedica Corp. shares in Q2 2025, an estimated $1.46K.
  • Signal Advisors Wealth first reported a position in Zomedica Corp. in Q1 2024 and held it in 5 quarters.
  • Signal Advisors Wealth's Zomedica Corp. position peaked at $3.65K in Q2 2024.
  • 10 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2025.

Based on Signal Advisors Wealth's 13F filing for Q2 2025, filed 10 Jul 2025.